Huixin Lifetech
Latest round
- Series A
Last raised
- Feb 2026
Total raised
- $14M
Investors
- 2
About Huixin Lifetech
, trading as Huixin Lifetech, is a medical equipment developer that provides tumor diagnosis-related products and services. The company has acquired more than 50 patents. In 2020, it was awarded as a small and micro-sized intellectual property advantage enterprise. Huixin Lifetech developed automated non-labeled exosome separation and purification technology. As well as it developed exosome detection technology for early cancer diagnosis, based on exosome separation technology. The company's main products include EXODUS automatic exocrine purification system and tumor early screening. EXODUS automatic exosomes purification system removes cells and cell fragments through centrifugation or filtration and then separates and purifies samples. The company generates revenue by providing fully automated exosome extraction system, cancer detection kits, and MyoYan™ Super Active Exosomes platform.
Who invested in Huixin Lifetech
2 investors across 2 rounds
See all investors in Huixin Lifetech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Huixin Lifetech
Who invested in Huixin Lifetech?
Huixin Lifetech has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Huixin Lifetech raised?
Huixin Lifetech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Huixin Lifetech last raise money?
Huixin Lifetech's most recent round on record is a Series A, in Feb 2026.
What does Huixin Lifetech do?
, trading as Huixin Lifetech, is a medical equipment developer that provides tumor diagnosis-related products and services.
Where is Huixin Lifetech headquartered?
Huixin Lifetech is headquartered in Shenzhen, China.
Which VCs invest in companies like Huixin Lifetech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Huixin Lifetech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Huixin Lifetech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.